Exact Mass: 362.19876600000003
Exact Mass Matches: 362.19876600000003
Found 500 metabolites which its exact mass value is equals to given mass value 362.19876600000003,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Cortisol
Cortisol is the main glucocorticoid secreted by the adrenal cortex and it is involved in the stress response. Its synthetic counterpart hydrocortisone is used, either as an injection or topically, in the treatment of inflammation, allergy, collagen diseases, asthma, adrenocortical deficiency, shock, and some neoplastic conditions. Hydrocortisone is synthesized from pregnenolone and is used as an immunosuppressive drug given by injection in the treatment of severe allergic reactions such as anaphylaxis and angioedema, in place of prednisolone in patients who need steroid treatment but cannot take oral medication, and peri-operatively in patients on long-term steroid treatment to prevent an Addisonian crisis. Cortisol increases blood pressure, blood sugar levels, may cause infertility in women, and suppresses the immune system. The amount of cortisol present in the serum undergoes diurnal variation, with the highest levels present in the early morning and lower levels in the evening, several hours after the onset of sleep. Cortisol is found to be associated with ACTH deficiency and glucocorticoid deficiency, which are inborn errors of metabolism. Cortisol binds to the cytosolic glucocorticoid receptor. After binding the receptor, the newly formed receptor-ligand complex translocates itself into the cell nucleus where it binds to many glucocorticoid response elements (GRE) in the promoter region of the target genes. The DNA-bound receptor then interacts with basic transcription factors, causing the increase in expression of specific target genes. The anti-inflammatory actions of corticosteroids are thought to involve lipocortins, phospholipase A2 inhibitory proteins which, through inhibition arachidonic acid, control the biosynthesis of prostaglandins and leukotrienes. Specifically, glucocorticoids induce lipocortin-1 (annexin-1) synthesis, which then binds to cell membranes and prevents phospholipase A2 from coming into contact with its substrate arachidonic acid. This leads to diminished eicosanoid production. The cyclooxygenase (both COX-1 and COX-2) expression is also suppressed, potentiating the effect. In other words, the two main products of inflammation, prostaglandins and leukotrienes, are inhibited by the action of glucocorticoids. Glucocorticoids also stimulate the escape of lipocortin-1 into the extracellular space, where it binds to the leukocyte membrane receptors and inhibits various inflammatory events: epithelial adhesion, emigration, chemotaxis, phagocytosis, respiratory burst, and the release of various inflammatory mediators (lysosomal enzymes, cytokines, tissue plasminogen activator, chemokines, etc.) from neutrophils, macrophages, and mastocytes. Additionally, the immune system is suppressed by corticosteroids due to a decrease in the function of the lymphatic system, a reduction in immunoglobulin and complement concentrations, the precipitation of lymphocytopenia, and interference with antigen-antibody binding. Cortisol is a steroid hormone, in the glucocorticoid class of hormones and a stress hormone. When used as a medication, it is known as hydrocortisone. It is produced in many animals, mainly by the zona fasciculata of the adrenal cortex in the adrenal gland.[1] It is produced in other tissues in lower quantities.[2] It is released with a diurnal cycle and its release is increased in response to stress and low blood-glucose concentration.[1] It functions to increase blood sugar through gluconeogenesis, to suppress the immune system, and to aid in the metabolism of fat, protein, and carbohydrates.[3] It also decreases bone formation.[4] Many of these functions are carried out by cortisol binding to glucocorticoid or mineralocorticoid receptors inside the cell, which then bind to DNA to affect gene expression.[1][5] Hydrocortisone (Cortisol) is a steroid hormone or glucocorticoid secreted by the adrenal cortex[1].
Humulone
An optically active cyclic ketone consisting of 3,5,6-trihydroxycyclohexa-2,4-dien-1-one bearing two 3-methylbut-2-en-1-yl substituents at positions 4 and 6 as well as a 3-methylbutanoyl group at the 2-position. Humulone is a natural product found in Humulus lupulus with data available. Humulone (α-Lupulic acid), a prenylated phloroglucinol derivative, is a potent cyclooxygenase-2 (COX-2) inhibitor. Humulone acts as a positive modulator of GABAA receptor at low micromolar concentrations. Humulone is an inhibitor of bone resorption. Humulone possesses antioxidant, anti-angiogenic and apoptosis-inducing properties[1][2][3]. Humulone (α-Lupulic acid), a prenylated phloroglucinol derivative, is a potent cyclooxygenase-2 (COX-2) inhibitor. Humulone acts as a positive modulator of GABAA receptor at low micromolar concentrations. Humulone is an inhibitor of bone resorption. Humulone possesses antioxidant, anti-angiogenic and apoptosis-inducing properties[1][2][3].
18-Hydroxycorticosterone
18-Hydroxycorticosterone is a corticosteroid and a derivative of corticosterone. If it is present in sufficiently high concentrations, it can lead to serious electrolyte imbalances (an electrolyte toxin). 18-Hydroxycorticosterone serves as an intermediate in the synthesis of aldosterone by the enzyme aldosterone synthase in the zona glomerulosa. Chronically high levels of 18-hydroxycorticosterone are associated with at least three inborn errors of metabolism including adrenal hyperplasia type V, corticosterone methyl oxidase I deficiency, and corticosterone methyl oxidase II deficiency. Each of these conditions is characterized by excessive amounts of sodium being released in the urine (salt wasting), along with insufficient release of potassium in the urine, usually beginning in the first few weeks of life. This imbalance leads to low levels of sodium and high levels of potassium in the blood (hyponatremia and hyperkalemia, respectively). Individuals with corticosterone methyloxidase deficiency can also have high levels of acid in the blood (metabolic acidosis). Acidosis typically occurs when arterial pH falls below 7.35. In infants with acidosis the initial symptoms include poor feeding, vomiting, loss of appetite, weak muscle tone (hypotonia), and lack of energy (lethargy). The hyponatremia, hyperkalemia, and metabolic acidosis associated with corticosterone methyloxidase deficiency can cause nausea, vomiting, dehydration, low blood pressure, extreme tiredness (fatigue), and muscle weakness. 11 beta,18,21-Trihydroxypregn-4-ene-3,20-dione. 18-Hydroxycorticosterone is a derivative of corticosterone. It serves as an intermediate in the synthesis of aldosterone by the enzyme aldosterone synthase in the zona glomerulosa. [HMDB] D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones
5beta-Dihydroaldosterone
A 3-oxo-5beta-steroid formed from aldosterone by reduction across the C4-C5 double bond.
Poststerone
D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones Origin: Plant, Pregnanes
16alpha-Hydroxycorticosterone
17,21-Epoxy-9-fluoro-11beta-hydroxyprogesterone
17a,21-Dihydroxy-5b-pregnane-3,11,20-trione
17alpha,21-Dihydroxy-5beta-pregnane-3,11,20-trione is an intermediate in C21-Steroid hormone metabolism. 17alpha,21-Dihydroxy-5beta-pregnane-3,11,20-trione is the second to last step in the synthesis of Cortolone and is converted. from Cortisone via the enzyme Delta4-3-oxosteroid 5beta-reductase (EC 1.3.1.3). It is then converted to Urocortisone via the enzyme 3-alpha-hydroxysteroid dehydrogenase (EC 1.1.1.50). 17alpha,21-Dihydroxy-5beta-pregnane-3,11,20-trione is an intermediate in C21-Steroid hormone metabolism. 17alpha,21-Dihydroxy-5beta-pregnane-3,11,20-trione is the second to last step in the synthesis of Cortolone and is converted
5-Hydroxy-4-methoxy-5-(1-oxo-9,12,15-hexadecatrienyl)-2(5H)-furanone
5-Hydroxy-4-methoxy-5-(1-oxo-9,12,15-hexadecatrienyl)-2(5H)-furanone is found in cereals and cereal products. 5-Hydroxy-4-methoxy-5-(1-oxo-9,12,15-hexadecatrienyl)-2(5H)-furanone is a constituent of etiolated seedlings of Sorghum bicolor (sorghum)
(R)-Humulone
(R)-Humulone is found in alcoholic beverages. (R)-Humulone is a constituent of hops. Constituent of hops. (R)-Humulone is found in alcoholic beverages.
Isohumulone A
Isohumulone B is found in alcoholic beverages. Isohumulone B is found in beer as isomer produced of Humulon
Adhumulone
Adhumulone is found in alcoholic beverages. Adhumulone is a constituent of hops Constituent of hops. Adhumulone is found in tea and alcoholic beverages.
11-Epicortisol
N-(4-Fluorophenyl)-4,5-dimethyl-6-[(1S)-1-methyl-3,4-dihydro-1H-isoquinolin-2-YL]pyrimidin-2-amine
C22H23FN4 (362.19066499999997)
C78276 - Agent Affecting Digestive System or Metabolism > C29701 - Anti-ulcer Agent
1alpha-Hydroxycorticosterone
Benzetimide
D002491 - Central Nervous System Agents > D018726 - Anti-Dyskinesia Agents > D000978 - Antiparkinson Agents C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C29704 - Antimuscarinic Agent D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D010276 - Parasympatholytics D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D018680 - Cholinergic Antagonists
1,4,6-Trihydroxy-1,3-bis(2-isopentenyl)-5-isovaleryl-3,5-cyclohexadien-2-on
4-Hydroxy-2-(3-methylbutanoyl)-5-(3-methylbut-2-enyl)-4-(4-methylpent-2-enoyl)cyclopentane-1,3-dione
Hydrocortisone
A - Alimentary tract and metabolism > A07 - Antidiarrheals, intestinal antiinflammatory/antiinfective agents > A07E - Intestinal antiinflammatory agents > A07EA - Corticosteroids acting locally H - Systemic hormonal preparations, excl. sex hormones and insulins > H02 - Corticosteroids for systemic use > H02A - Corticosteroids for systemic use, plain > H02AB - Glucocorticoids S - Sensory organs > S01 - Ophthalmologicals > S01C - Antiinflammatory agents and antiinfectives in combination > S01CB - Corticosteroids/antiinfectives/mydriatics in combination D - Dermatologicals > D07 - Corticosteroids, dermatological preparations > D07X - Corticosteroids, other combinations > D07XA - Corticosteroids, weak, other combinations A - Alimentary tract and metabolism > A01 - Stomatological preparations > A01A - Stomatological preparations > A01AC - Corticosteroids for local oral treatment C - Cardiovascular system > C05 - Vasoprotectives > C05A - Agents for treatment of hemorrhoids and anal fissures for topical use > C05AA - Corticosteroids D - Dermatologicals > D07 - Corticosteroids, dermatological preparations > D07A - Corticosteroids, plain > D07AA - Corticosteroids, weak (group i) S - Sensory organs > S01 - Ophthalmologicals > S01B - Antiinflammatory agents > S01BA - Corticosteroids, plain C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C308 - Immunotherapeutic Agent > C574 - Immunosuppressant > C211 - Therapeutic Corticosteroid S - Sensory organs > S02 - Otologicals > S02B - Corticosteroids > S02BA - Corticosteroids D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials relative retention time with respect to 9-anthracene Carboxylic Acid is 1.008 relative retention time with respect to 9-anthracene Carboxylic Acid is 1.006 CONFIDENCE standard compound; EAWAG_UCHEM_ID 3201 CONFIDENCE standard compound; INTERNAL_ID 2809 D000893 - Anti-Inflammatory Agents Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS Hydrocortisone (Cortisol) is a steroid hormone or glucocorticoid secreted by the adrenal cortex[1].
3beta-Angeloyloxy-4beta-hydroxy-delta5-costic aid methyl ester
ent-16-Acetoxy-8-oxo-17-nor-6,13E-labdadien-15-oic acid
11beta-Acetoxy-5alpha-isobutyryloxysilphinen-3-one
Methyl 6.alpha.,7.beta.-dihydroxyvouacapan-17.beta.-oate
16-Methoxy-labda-8(17),13-diene-15,19-dioic acid butenolide
17,18,19,20-tetranor-13-epi-manoyloxide-14-en-16-oic acid 23,6alpha-olide
methyl 9beta,13beta-epidioxyabiet-8(14)-en-18-oate
(6beta,11beta)-6,11,21-Trihydroxypregn-4-ene-3,20-dione
(3R)-8-hydroxy-6-methoxy-3-(7-oxoundecyl)-3,4-dihydroisocoumarin
methyl 6-alpha-hydroxycleroda-3,13-dien-15,16-olid-18-oate|PC-66-633-1
enaimeone B|rel-(1R,5R,6R)-4-hydroxy-6-(1-hydroxy-1-methylethyl)-5-methyl-1-(3-methylbut-2-enyl)-3-(2-methylpropanoyl)bicyclo[3.2.1]oct-3-ene-2,8-dione
2beta-methoxycleroda-3,13-dien-18-carboxy-15,16-olide
11beta,19,21-Trihydroxy-pregn-4-en-3,20-dion|11beta,19,21-trihydroxy-pregn-4-ene-3,20-dione|19-hydroxycorticosterone
(16S)-6alpha-methoxy-6,7-seco-6,19-epoxy-7,20-olide-ent-kaur-15-one|ludongnin G
rel-(3R,4S,4aS,6aS,7aS,8S,8aR,9aR,9bS)-dodecahydro-3-hydroxy-4,9b-dimethyl-6,8-methano-6aH-cyclopropa[b]phenanthrene-4,7a(7H)-dicarboxylic acid 4-methyl ester
(3R,4S,5R,7S,9R)-3-acetoxy-9-(2-methylpropionyloxy)solavetivone
caesalpinista A|methyl (4S,4aR,5R,6aS,7R,11aS,11bS)-1,2,3,4,4a,5,6,6a,7,11,11a,11b-dodecahydro-5-hydroxy-11b-(hydroxymethyl)-4,7-dimethylphenanthro[3,2-b]furan-4-carboxylate
1-hydroxyialibinone B|rel-(2R,3aR,7R,8aR)-1,2,3,7,8,8a-hexahydro-6-hydroxy-2-(1-hydroxy-1-methylethyl)-1,1,7-trimethyl-5-(2-methylpropanoyl)-4H-3a,7-methanoazulene-4,9-dione
4alpha-Hydroxy-6beta-isobutyryloxy-9-oxofuranoeremophilon
methyl ent-6,16-dioxo-8,12-oxido-labda-13Z-en-15-oate
3,4-Dihydro-8-hydroxy-6-methoxy-3-(6-oxoundecyl)-1H-2-benzopyran-1-one
ent-16,17-dihydroxykauran-19-oic acid 16,17-acetonide
(2R?)-2-Hydroxy-2,4-bis-(3-methyl-but-2-enyl)-6-((Xi)-2-methyl-butyryl)-cyclohexan-1,3,5-trion|(2R?)-2-hydroxy-2,4-bis-(3-methyl-but-2-enyl)-6-((Xi)-2-methyl-butyryl)-cyclohexane-1,3,5-trione
8,8-dimethyl-2-(1-methyl-ethyl)-4b-hydroxymethyl-1,4-hydroxy-3-methoxy-4b,5,6,7,8,8a,9,10-octahydro-phenanthren-10-one
1alpha-angeloyloxy-8beta-methoxyeremophil-7(11)-en-12,8alpha-olide
15-methoxy-ent-cleroda-3,13-diene-17-oic acid-16,15-olide
5-hydroxy-3(S)-(1(S)-hydroxy-4-oxopentyl)-2,2-dimethyl-7-n-pentylchroman-4-one|cannabichromanone B
8,10-Diacetoxy-9-hydroxy-heptadecan-1,9-en-11,13-diin|Ciryneol E
1-(3-((3,3-dimethyloxiran-2-yl)methyl)-2,4,6-trihydroxy-5-(3-methylbut-2-en-1-yl)phenyl)-2-methylbutan-1-one
2beta-hydroxy-3beta-methylsenecioyloxyeremophil-7(11)-en-8alpha(12)-olide
Me ester-8, 11-Dihydroxy-12-oxo-13, 15(17)-abietadien-16-oic acid
9R-(beta-D-glucopyranosyloxy)-cis-cascarillic acid|parisveroside A
monascuspurpurone|rel-(1S,7aR,3aR)-1-hexanoyl-5,13-dimethyl-6-(2-oxopentyl)-7a,7-dihydrobenzofuran-2,4-dione|rel-(1S,7aR,3aR)-3a,7a-dihydro-3-hexanoyl-6,7a-dimethyl-5-(2-oxopentyl)-1-benzofuran-2,7-(3H,4H)-dione
1-[3,5,7-trihydroxy-2-methyl-2-(4-methylpent-3-enyl)- chroman-8-yl]-2-methylbutan-1-one|empetrikarinol B
1-(2,6,8-trihydroxy-1,1,4a-trimethyl-2,3,4,4a,9,9a-hexahydro-1H-xanthen-5-yl)-2-methylbutan-1-one|empetriferdinol
4,6-dihydroxy-2-O-(6,7-epoxy-3,7-dimethyl-2,7-octadienyl)-1-(2-methylbutanoyl)benzene|olympicin E
(6beta,7alpha)-6,12-dihydroxy-7-methoxyabieta-8,12-diene-11,14-dione|6beta-hydroxy-7alpha-methoxyroyleanone
4,6-dihydroxy-2-O-(7-hydroxy-3,7-dimethyl-2,5-octadienyl)-1-(2-methylbutanoyl)benzene|olympicin B
1-[2,3-dihydro-4,6-dihydroxy-2-(1-hydroxy-1-methylethyl)-5-(3-methylbut-2-en-1-yl)-1-benzofuran-7-yl]-3-methylbutan-1-one|5-deprenyllupulonol C
15alpha-hydroxy-6beta-methoxy-6,7-seco-6,20-epoxy-ent-kaur-16-en-1,7-olide|serrin D
4,6-dihydroxy-2-O-(6-hydroxy-3,7-dimethyl-2,7-octadienyl)-1-(2-methylbutanoyl)benzene|olympicin C
methyl ester of 15-hydroxy-16-oxo-15,16H-hardwickiic acid|methyl ester of 15-hydroxycleroda-3,13-dien-15,16-olide-18-oic acid
11beta-acetoxy-5alpha-isobutyryloxy-silphinen-3-one|11beta-acetoxy-5alpha-isobutyryloxysilphinen-3-one
1beta-hydroxy-2beta-methylsenecioyloxyeremophil-7(11)-en-8beta(12)-olide
(+)-7beta-acetoxy-3-oxo-18-nor-13-cleroden-16,15-olide|Ac-7beta-7-Hydroxy-18-nor-3-oxo-13-cleroden-16,15-olide
(R)-Humulone
18-O-butanedioylpodocarpen-8(14)-en-13-one|abiesanordine D
9,10-Diacetoxy-8-hydroxy-heptadecan-1,9-en-11,13-diin
12,17-dihydroxyhardwickiic acid methyl ester|Me ester-(ent-12R)-15,16-Epoxy-12,17-dihydroxy-3,13(16),14-clerodatrien-18-oic acid
17,19,21-Trihydroxy-pregn-4-en-3,20-dion|17,19,21-trihydroxy-pregn-4-ene-3,20-dione|17alpha,19,21-Trihydroxy-pregn-4-en-3,20-dion
4-O-[(2E,5E)-3,7-Dimethyl-2,5-octadiene-7-ol]-sinapyl alcohol
(3S,5R,10S)-7-oxo-12-methoxyabieta-8,11,13-triene-3,11,14-triol
(1aS,3aS,4E,7aR,10R,10aS)-10-hydroxy-4-[(2E)-4-methoxy-4-methylpent-2-en-1-ylidene]-1a-methyl-8-methylidenedecahydrooxireno[5,6]cyclonona[1,2-c]pyran-5(1aH)-one|asterolaurin J
5,6-dihydroxy-4-(3-methylbutanoyl)-2,6-bis(3-methylbut-2-en-1-yl)cyclohex-4-ene-1,3-dione
(+)-(1betaH,7E)-6-beta-acetoxy-11beta-hydroxynorverticilla-4(18),7-diene-10,12-dione|(1R,4E,6S,11R)-1-hydroxy-4,15,15-trimethyl-8-methylidene-2,14-dioxobicyclo[9.3.1]pentadec-4-en-6-yl acetate|cespihypotin X
2-methyl-6-[(3aS,7S,9aR)-3,3a,5,6,7,8,9,9a-octahydro-7-hydroxy-3a-methyl-8-oxocyclopenta[b]chromen-1-yl]heptanoic aicd|TCA C
6-(3-Methylpentanoyl)-1,10-Epoxyfuranoeremophilane-3,6-diol
3,5,6-trihydroxy-2-(2-methylbutanoyl)-4,6-bis(3-methylbut-2-en-1-yl)cyclohexa-2,4-dien-1-one
Hydrocortisone
A - Alimentary tract and metabolism > A07 - Antidiarrheals, intestinal antiinflammatory/antiinfective agents > A07E - Intestinal antiinflammatory agents > A07EA - Corticosteroids acting locally H - Systemic hormonal preparations, excl. sex hormones and insulins > H02 - Corticosteroids for systemic use > H02A - Corticosteroids for systemic use, plain > H02AB - Glucocorticoids S - Sensory organs > S01 - Ophthalmologicals > S01C - Antiinflammatory agents and antiinfectives in combination > S01CB - Corticosteroids/antiinfectives/mydriatics in combination D - Dermatologicals > D07 - Corticosteroids, dermatological preparations > D07X - Corticosteroids, other combinations > D07XA - Corticosteroids, weak, other combinations A - Alimentary tract and metabolism > A01 - Stomatological preparations > A01A - Stomatological preparations > A01AC - Corticosteroids for local oral treatment C - Cardiovascular system > C05 - Vasoprotectives > C05A - Agents for treatment of hemorrhoids and anal fissures for topical use > C05AA - Corticosteroids D - Dermatologicals > D07 - Corticosteroids, dermatological preparations > D07A - Corticosteroids, plain > D07AA - Corticosteroids, weak (group i) S - Sensory organs > S01 - Ophthalmologicals > S01B - Antiinflammatory agents > S01BA - Corticosteroids, plain C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C308 - Immunotherapeutic Agent > C574 - Immunosuppressant > C211 - Therapeutic Corticosteroid S - Sensory organs > S02 - Otologicals > S02B - Corticosteroids > S02BA - Corticosteroids D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials D000893 - Anti-Inflammatory Agents Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS Hydrocortisone (Cortisol) is a steroid hormone or glucocorticoid secreted by the adrenal cortex[1].
Cortisol
A 17alpha-hydroxy-C21-steroid that is pregn-4-ene substituted by oxo groups at positions 3 and 20 and hydroxy groups at positions 11, 17 and 21. Cortisol is a corticosteroid hormone or glucocorticoid produced by zona fasciculata of the adrenal cortex, which is a part of the adrenal gland. It is usually referred to as the "stress hormone" as it is involved in response to stress and anxiety, controlled by corticotropin-releasing hormone (CRH). It increases blood pressure and blood sugar, and reduces immune responses. Cortisol is a corticosteroid hormone produced by the adrenal cortex that is involved in the response to stress; The main glucocorticoid secreted by the adrenal cortex. Its synthetic counterpart is used, either as an injection or topically, in the treatment of inflammation, allergy, collagen diseases, asthma, adrenocortical deficiency, shock, and some neoplastic conditions.; As an oral or injectable drug, cortisol is also known as hydrocortisone. It is used as an immunosuppressive drug, given by injection in the treatment of severe allergic reactions such as anaphylaxis and angioedema, in place of prednisolone in patients who need steroid treatment but cannot take oral medication, and peri-operatively in patients on long-term steroid treatment to prevent an Addisonian crisis.; Cortisol or Hydrocortisone is a corticosteroid hormone produced by the adrenal cortex that is involved in the response to stress. It increases blood pressure, blood sugar levels, may cause infertility in women, and suppresses the immune system. Its synthetic counterpart (hydrocortisone) is used, either as an injection or topically, in the treatment of inflammation, allergy, collagen diseases, asthma, adrenocortical deficiency, shock, and some neoplastic conditions. Cortisol is synthesized from pregnenolone. The amount of cortisol present in the serum undergoes diurnal variation, with the highest levels present in the early morning, and lower levels in the evening, several hours after the onset of sleep.; Cortisol is a corticosteroid hormone produced by the adrenal cortex that is involved in the response to stress; it increases blood pressure, blood sugar levels, may cause infertility in women, and suppresses the immune system. Synthetic cortisol, also known as hydrocortisone, is used as a drug mainly to fight allergies and inflammation; it increases blood pressure, blood sugar levels, may cause infertility in women, and suppresses the immune system. Synthetic cortisol, also known as hydrocortisone, is used as a drug mainly to fight allergies and inflammation. [HMDB] Hydrocortisone (Cortisol) is a steroid hormone or glucocorticoid secreted by the adrenal cortex[1].
Lovastatin derivative putative C21H30O5 observed in fungal symbiont H
(5Z,7E)-(1S,3R,17R)-1,3,17,21-tetrahydroxy-9,10-seco-5,7,10(19)-pregnatrien-20-one
Isohumulone A
Adhumulone
5-Hydroxy-4-methoxy-5-(1-oxo-9,12,15-hexadecatrienyl)-2(5H)-furanone
(±)-JWH 018 N-(4-hydroxypentyl) metabolite-d5
C24H18D5NO2 (362.20425568999997)
JWH 018 N-(5-hydroxypentyl) metabolite-d5
C24H18D5NO2 (362.20425568999997)
ST 21:3;O5
D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones
(4R,4R)-2,2-(PROPANE-2,2-DIYL)BIS(4-BENZYL-4,5-DIHYDROOXAZOLE)
solifenacin
G - Genito urinary system and sex hormones > G04 - Urologicals > G04B - Urologicals > G04BD - Drugs for urinary frequency and incontinence C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C29704 - Antimuscarinic Agent D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D018680 - Cholinergic Antagonists D000089162 - Genitourinary Agents > D064804 - Urological Agents Solifenacin (YM905 free base) is a novel muscarinic receptor antagonist with pKis of 7.6, 6.9 and 8.0 for M1, M2 and M3 receptors, respectively.
N,N-bis(2-aminoethyl)ethane-1,2-diamine,2-(chloromethyl)oxirane,formaldehyde,phenol
N-(2-((tert-Butyldimethylsilyloxy)methyl)furo[3,2-b]pyridin-7-yl)pivalamide
4-PREGNENE-17-A-20-B-21-TRIOL-*3-11-DION E
D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones
sodium n-tridecylbenzenesulfonate
C19H31NaO3S (362.18914960000006)
4,4-DIISOCYANATO-3,3,5,5-TETRAETHYLDIPHENYLMETHANE
Dexetimide
D002491 - Central Nervous System Agents > D018726 - Anti-Dyskinesia Agents > D000978 - Antiparkinson Agents N - Nervous system > N04 - Anti-parkinson drugs > N04A - Anticholinergic agents > N04AA - Tertiary amines C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C29704 - Antimuscarinic Agent D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D010276 - Parasympatholytics D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D018680 - Cholinergic Antagonists Dexetimide ((+)-Benzetimide; (S)-(+)-Dexetimide; Dexbenzetimide) is a piperidine anticholinergic and a high-affinity muscarinic receptor antagonist. Dexetimide can be used in studies of parkinson's disease[1][2].
11-Epicortisol
D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones D000893 - Anti-Inflammatory Agents
2-hydroxyethyl 2-methylprop-2-enoate,2-methylidenehexanoic acid,styrene
EPOXYPROPOXYPROPYL TERMINATED POLYDIMETHYLSILOXANE
2,8-Diazaspiro[5.5]undecane-1,7-dione, 2,8-bis(phenylmethyl)-
1-[4-[1-(3-methoxy-4-nitrophenyl)piperidin-4-yl]piperazin-1-yl]ethanone
C18H26N4O4 (362.19539560000004)
Clometherone
C274 - Antineoplastic Agent > C129818 - Antineoplastic Hormonal/Endocrine Agent > C481 - Antiestrogen C147908 - Hormone Therapy Agent > C547 - Hormone Antagonist
3,5,6-Trihydroxy-2-(2-methylbutanoyl)-4,6-bis(3-methylbut-2-enyl)cyclohexa-2,4-dien-1-one
18-Hydroxy-11-deoxycortisol
D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones
(6S)-6-Cyclopentyl-6-[2-(3-fluoro-4-isopropoxyphenyl)ethyl]-4-hydroxy-5,6-dihydro-2H-pyran-2-one
benzetimide
D002491 - Central Nervous System Agents > D018726 - Anti-Dyskinesia Agents > D000978 - Antiparkinson Agents C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C29704 - Antimuscarinic Agent D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D010276 - Parasympatholytics D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D018680 - Cholinergic Antagonists
(8S,9S,10R,11S,13S,14S,17S)-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-3-one
(4R)-3,4,5-Trihydroxy-4,6-bis(3-methyl-2-butenyl)-2-(2-methylbutyryl)-2,5-cyclohexadien-1-one
(4R)-3,4-dihydroxy-2-(3-methylbutanoyl)-5-(3-methylbut-2-enyl)-4-(4-methylpent-3-enoyl)cyclopent-2-en-1-one
(1E,3S,10R,11S)-3,9,14-trihydroxy-14-(methoxymethyl)-10-methyl-4-methylidene-6-propan-2-yltricyclo[9.3.0.03,7]tetradeca-1,6-dien-5-one
4-Hydroxy-2-(3-methylbutanoyl)-5-(3-methylbut-2-enyl)-4-(4-methylpent-2-enoyl)cyclopentane-1,3-dione
5-(Phenylmethoxymethyl)-7-(1-piperidinylmethyl)-8-quinolinol
(1S,2S,5R,8S,9R,11R,15S,16S,18R)-15,18-dihydroxy-16-methoxy-12,12-dimethyl-6-methylidene-17-oxapentacyclo[7.6.2.15,8.01,11.02,8]octadecan-7-one
(4S)-4-phenyl-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid [(3R)-1-azabicyclo[2.2.2]octan-3-yl] ester
(11beta,20R)-11,17,20,21-Tetrahydroxypregna-1,4-dien-3-one
17,21-Epoxy-9-fluoro-11-hydroxypregn-4-ene-3,20-dione, (11beta)-
N(6)-L-homocysteinyl-N(2)-L-valyl-L-lysine
C15H30N4O4S (362.19876600000003)
1-[(4-Chlorophenyl)-[1-(2-methylbutan-2-yl)-5-tetrazolyl]methyl]-4-methylpiperazine
7-Hydroxy-2,6,6,10,14-pentamethyl-11,13-dioxatetracyclo[8.8.0.02,7.012,17]octadec-12(17)-ene-3,16-dione
N-[2-[(2R,5S,6R)-5-[[cyclobutyl(oxo)methyl]amino]-6-(hydroxymethyl)-2-oxanyl]ethyl]-2-pyrazinecarboxamide
C18H26N4O4 (362.19539560000004)
N-[2-[(2R,5R,6S)-5-[[cyclobutyl(oxo)methyl]amino]-6-(hydroxymethyl)-2-oxanyl]ethyl]-2-pyrazinecarboxamide
C18H26N4O4 (362.19539560000004)
N-[2-[(2S,5S,6S)-5-[[cyclobutyl(oxo)methyl]amino]-6-(hydroxymethyl)-2-oxanyl]ethyl]-2-pyrazinecarboxamide
C18H26N4O4 (362.19539560000004)
1-[(3aR,4R,9bR)-4-(hydroxymethyl)-8-phenyl-2,3,3a,4,5,9b-hexahydropyrrolo[3,2-c]quinolin-1-yl]-2-cyclopropylethanone
(6S,7S,8R)-4-benzyl-8-(hydroxymethyl)-7-[4-[(E)-prop-1-enyl]phenyl]-1,4-diazabicyclo[4.2.0]octan-2-one
N-[2-[(2S,5R,6S)-5-[[cyclobutyl(oxo)methyl]amino]-6-(hydroxymethyl)-2-oxanyl]ethyl]-2-pyrazinecarboxamide
C18H26N4O4 (362.19539560000004)
N-[2-[(2R,5R,6R)-5-[[cyclobutyl(oxo)methyl]amino]-6-(hydroxymethyl)-2-oxanyl]ethyl]-2-pyrazinecarboxamide
C18H26N4O4 (362.19539560000004)
N-[2-[(2R,5S,6S)-5-[[cyclobutyl(oxo)methyl]amino]-6-(hydroxymethyl)-2-oxanyl]ethyl]-2-pyrazinecarboxamide
C18H26N4O4 (362.19539560000004)
N-[2-[(2S,5S,6R)-5-[[cyclobutyl(oxo)methyl]amino]-6-(hydroxymethyl)-2-oxanyl]ethyl]-2-pyrazinecarboxamide
C18H26N4O4 (362.19539560000004)
N-[2-[(2S,5R,6R)-5-[[cyclobutyl(oxo)methyl]amino]-6-(hydroxymethyl)-2-oxanyl]ethyl]-2-pyrazinecarboxamide
C18H26N4O4 (362.19539560000004)
1-[(3aS,4R,9bS)-4-(hydroxymethyl)-8-phenyl-2,3,3a,4,5,9b-hexahydropyrrolo[3,2-c]quinolin-1-yl]-2-cyclopropylethanone
1-[(3aS,4S,9bS)-4-(hydroxymethyl)-8-phenyl-2,3,3a,4,5,9b-hexahydropyrrolo[3,2-c]quinolin-1-yl]-2-cyclopropylethanone
1-[(3aR,4S,9bR)-4-(hydroxymethyl)-8-phenyl-2,3,3a,4,5,9b-hexahydropyrrolo[3,2-c]quinolin-1-yl]-2-cyclopropylethanone
(6R,7S,8R)-4-benzyl-8-(hydroxymethyl)-7-[4-[(E)-prop-1-enyl]phenyl]-1,4-diazabicyclo[4.2.0]octan-2-one
(8S,9S,10R,11S,13S,14R,17R)-11,17-dihydroxy-17-(2-hydroxy-1-oxoethyl)-10,13-dimethyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-3-one
(9xi,17xi)-2,3,14-Trihydroxypregn-7-ene-6,20-dione
18-Hydroxycorticosterone
A 18-hydroxy steroid that is corticosterone substituted by a hydroxy group at position 18. D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones
revaprazan
C22H23FN4 (362.19066499999997)
C78276 - Agent Affecting Digestive System or Metabolism > C29701 - Anti-ulcer Agent
20beta-hydroxycortisone
A C21-steroid that is cortisone in which the oxo group at position 20 is replaced by a hydroxy group.
(+)-cis-isohumulone
A cyclic ketone that is the naturally occurring (4S,5R) enantiomer of the cis-isomer of isohumolone, produced during the brewing process due to thermal isomerism, which converts humulones to isohumulones via an acyloin-type ring contraction.
20beta-dihydroprednisolone
A glucocorticoid that is prednisolone in which the oxo group at position 20 has been reduced to the corresponding beta-hydroxy group. It is a metabolite of prednisolone.
Levetimide
Levetimide is a potent and stereoselective inhibitor of [3H](+)pentazocine binding, with a Ki of 2.2 nM[1].
methyl 12-isopropyl-2,6-dimethyl-9-oxo-13,14-dioxatetracyclo[10.2.2.0¹,¹⁰.0²,⁷]hexadec-10-ene-6-carboxylate
methyl (4ar,5s,6r,8ar)-5-{2-[(5s)-5-hydroxy-2-oxo-5h-furan-3-yl]ethyl}-5,6,8a-trimethyl-3,4,4a,6,7,8-hexahydronaphthalene-1-carboxylate
(2s,6r)-6-[(3s,7r,11s)-11-hydroxy-3-methyl-10-oxo-2-oxatricyclo[7.4.0.0³,⁷]trideca-1(9),5-dien-6-yl]-2-methylheptanoic acid
(3s,4s,5s)-3-[9-(2h-1,3-benzodioxol-5-yl)nonyl]-4-hydroxy-5-methyloxolan-2-one
(4as,5r,6s,8ar,9ar)-9a-methoxy-3,4a,5-trimethyl-2-oxo-4h,5h,6h,7h,8h,8ah,9h-naphtho[2,3-b]furan-6-yl (2z)-2-methylbut-2-enoate
9a-methoxy-3,4a,5-trimethyl-2-oxo-4h,5h,6h,7h,8h,8ah,9h-naphtho[2,3-b]furan-8-yl 2-methylbut-2-enoate
4-hydroxy-6-(2-hydroxypropan-2-yl)-5-methyl-1-(3-methylbut-2-en-1-yl)-3-(2-methylpropanoyl)bicyclo[3.2.1]oct-3-ene-2,8-dione
(1r,2s,4as,7r)-1-hydroxy-7-(3-methoxy-3-oxoprop-1-en-2-yl)-1,4a-dimethyl-2,3,4,5,6,7-hexahydronaphthalen-2-yl (2z)-2-methylbut-2-enoate
2-methyl-1-[(2s,3r)-3,5,7-trihydroxy-2,6-dimethyl-2-(4-methylpent-3-en-1-yl)-3,4-dihydro-1-benzopyran-8-yl]propan-1-one
(1s,4s,9r,12s,13r,16r,17r)-17-hydroxy-17-(hydroxymethyl)-9-methoxy-12-methyl-8-oxapentacyclo[14.2.1.0¹,¹³.0⁴,¹².0⁵,⁹]nonadec-5-en-7-one
methyl (4ar,5r,6r,8ar)-5-[(2s)-2-(furan-3-yl)-2-hydroxyethyl]-6-(hydroxymethyl)-5,8a-dimethyl-3,4,4a,6,7,8-hexahydronaphthalene-1-carboxylate
methyl (4ar,4bs,8as,10s)-10-(acetyloxy)-4b,8,8-trimethyl-3-oxo-4,4a,5,6,7,8a,9,10-octahydro-2h-phenanthrene-1-carboxylate
methyl 8-hydroxy-6-isopropyl-9,13-dimethyl-5-oxo-15-oxatetracyclo[6.6.1.0¹,¹⁰.0⁴,⁹]pentadec-2-ene-3-carboxylate
1-[2-(5-methoxy-2-oxo-5h-furan-3-yl)ethyl]-1,4a,5-trimethyl-2,3,4,7,8,8a-hexahydronaphthalene-2-carboxylic acid
(1s,4r,5r)-4-[(3e,6s,8s)-11-(furan-3-yl)-6-hydroxy-4,8-dimethylundec-3-en-1-yl]-2,6-dioxabicyclo[3.1.0]hexan-3-one
4-[11-(furan-3-yl)-6-hydroxy-4,8-dimethylundec-3-en-1-yl]-5-hydroxy-5h-furan-2-one
5-oxo-3-[1-(1,3,3-trimethylcyclohexyl)buta-1,3-dien-2-yl]-tetrahydro-2h-furo[2,3-b]furan-2-yl acetate
5-[11-(furan-3-yl)-6-hydroxy-4,8-dimethylundec-3-en-1-yl]-2,6-dioxabicyclo[3.1.0]hexan-3-one
7-(1-methoxy-1-oxopropan-2-yl)-1,8a-dimethyl-6-oxo-1,2,3,4,4a,5-hexahydronaphthalen-2-yl 2-methylbut-2-enoate
4-(2-{9-methoxy-7,8-dimethyl-3-oxo-1h,5h,6h,6ah,8h,9h,10h-naphtho[4,4a-c]furan-7-yl}ethyl)oxolan-2-one
(1e,3s,9s,10r,11s,14r)-3,9,14-trihydroxy-6-isopropyl-14-(methoxymethyl)-10-methyl-4-methylidenetricyclo[9.3.0.0³,⁷]tetradeca-1,6-dien-5-one
4-hydroxy-2-methoxy-6,14,14-trimethyl-10-methylidene-3,16-dioxatetracyclo[11.3.2.0¹,¹⁵.0⁴,¹⁵]octadec-6-en-8-one
5,6-dihydroxy-2,6-bis(3-methylbut-2-en-1-yl)-4-(2-methylbutanoyl)cyclohex-4-ene-1,3-dione
(1s,5ar,7r,8s,9ar,9br,11ar)-1-acetyl-3a,7,8-trihydroxy-9a,11a-dimethyl-1h,2h,3h,5ah,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-5-one
3-[11-(furan-3-yl)-6-hydroxy-4,8-dimethylundec-3-en-1-yl]-5-hydroxy-5h-furan-2-one
2-[3-(furan-3-yl)propyl]-6-(methoxycarbonyl)-10-methylundeca-5,9-dienoic acid
8-[4-(3-hydroxyprop-1-en-1-yl)-2,6-dimethoxyphenoxy]-2,6-dimethylocta-1,6-dien-3-ol
8-hydroxy-3-(2-hydroxypropan-2-yl)-4,4,7-trimethyl-9-(2-methylpropanoyl)tricyclo[5.3.1.0¹,⁵]undec-8-ene-10,11-dione
(10r)-15-methoxypinusolidicacid
{"Ingredient_id": "HBIN000195","Ingredient_name": "(10r)-15-methoxypinusolidicacid","Alias": "NA","Ingredient_formula": "C21H30O5","Ingredient_Smile": "CC12CCCC(C1CCC(=C)C2CCC3=CC(OC3=O)OC)(C)C(=O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "14062","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
1,3,5-trihydroxy-6-[2''',3'''-epoxy-3'''-methyl-butyl]-2-[2''-methyl-butanoyl]-4-[3'-methyl-2'-butenyl]-benzene
{"Ingredient_id": "HBIN001068","Ingredient_name": "1,3,5-trihydroxy-6-[2''',3'''-epoxy-3'''-methyl-butyl]-2-[2''-methyl-butanoyl]-4-[3'-methyl-2'-butenyl]-benzene","Alias": "NA","Ingredient_formula": "C21H30O5","Ingredient_Smile": "CCC(C)C(=O)C1=C(C(=C(C(=C1O)CC2C(O2)(C)C)O)CC=C(C)C)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "21711","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
14,17,21-trihydroxypregn-4-ene-3,20-dione
{"Ingredient_id": "HBIN001324","Ingredient_name": "14,17,21-trihydroxypregn-4-ene-3,20-dione","Alias": "NA","Ingredient_formula": "C21H30O5","Ingredient_Smile": "CC12CCC(=O)C=C1CCC3C2CCC4(C3(CCC4(C(=O)CO)O)O)C","Ingredient_weight": "362.5 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "9323","PubChem_id": "101785","DrugBank_id": "NA"}
15-methoxypinusolidic acid
{"Ingredient_id": "HBIN001699","Ingredient_name": "15-methoxypinusolidic acid","Alias": "NA","Ingredient_formula": "C21H30O5","Ingredient_Smile": "CC12CCCC(C1CCC(=C)C2CCC3=CC(OC3=O)OC)(C)C(=O)O","Ingredient_weight": "362.5 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "19371","PubChem_id": "137706329","DrugBank_id": "NA"}
(2E,6E)- 3,7,11-trimethyl-9-(phenylsulfonyl)-2,6,10-dodecatrien-1-ol
{"Ingredient_id": "HBIN005569","Ingredient_name": "(2E,6E)- 3,7,11-trimethyl-9-(phenylsulfonyl)-2,6,10-dodecatrien-1-ol","Alias": "NA","Ingredient_formula": "C21H30O3S","Ingredient_Smile": "CC(=CC(CC(=CCCC(=CCO)C)C)S(=O)(=O)C1=CC=CC=C1)C","Ingredient_weight": "362.5 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "41632","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "5368759","DrugBank_id": "NA"}
4-o-[(2e,5 e)-3,7-dimethyl-2,5-octadiene-7-ol]-sinapyl alcohol
{"Ingredient_id": "HBIN010733","Ingredient_name": "4-o-[(2e,5 e)-3,7-dimethyl-2,5-octadiene-7-ol]-sinapyl alcohol","Alias": "NA","Ingredient_formula": "C21H30O5","Ingredient_Smile": "CC(=CCOC1=C(C=C(C=C1OC)C=CCO)OC)CC=CC(C)(C)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "6380","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
4-pregnene-17α,20β,21-triol-3,11-dione
{"Ingredient_id": "HBIN010825","Ingredient_name": "4-pregnene-17\u03b1,20\u03b2,21-triol-3,11-dione","Alias": "NA","Ingredient_formula": "C21H30O5","Ingredient_Smile": "CC12CCC(=O)C=C1CCC3C2C(CC4(C3CCC4(C(=O)CO)O)C)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "17790","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}